CBER Should Retain Jurisdiction of Assigned Device Reviews – HHS Report

Improved device review times, including speedy handling of West Nile Virus diagnostics, convinced HHS that the Center for Biologics Evaluation & Research should retain jurisdiction over blood and tissue-related devices already assigned to the center

More from Archive

More from Medtech Insight